ProQR spins out Amylon Therapeutics

ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of institutional and private investors. As part of...

Amylon Therapeutics announces seed investment round

Amylon Therapeutics announces seed investment round, focus on CNS disorders   Key updates Amylon Therapeutics B.V. is a spin-off company from ProQR Therapeutics N.V., a NASDAQ listed biopharmaceutical company based in Leiden, the Netherlands. Amylon announces the...